IL6 and breast carcinoma: When data from two randomised controlled exercise training trials in breast cancer patients were pooled and analysed together, the findings showed that exercise training (12–18 weeks of resistance or concurrent training) does not decrease the cancer/chemotherapy-induced levels of the inflammatory markers IL-6 and IL-6/IL-1ra ratio [97].